Ali-Jackson Kamil
Insider CIK 1654337 · RIGL Director · PDSB Director · ACRS Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2026-06-22 | 2026-06-24 | 2,500 | $35.00 | $87.5K | 10,125 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2026-05-26 | 2026-05-28 | 2,500 | $29.17 | $72.9K | 12,625 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2026-05-15 | 2026-05-19 | 5,750 | — | $0 | 15,125 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-05-23 | 2025-05-28 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2025-05-23 | 2025-05-28 | 2,500 | — | $0 | 9,375 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-05-25 | 2024-05-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2024-05-25 | 2024-05-29 | 25,000 | — | $0 | 68,750 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2023-05-26 | 2023-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2023-05-26 | 2023-07-12 | 25,000 | — | $0 | 43,750 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2022-05-20 | 2022-05-23 | 22,500 | — | $0 | 22,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2022-05-20 | 2022-05-23 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-05 | 3,875 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-05 | 7,100 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-05 | 27,905 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-05 | 6,638 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-05 | 7,100 | — | $0 | 160,214 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-05 | 27,905 | — | $0 | 146,476 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-05 | 6,638 | — | $0 | 153,114 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-05 | 3,875 | — | $0 | 118,571 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2021-12-16 | 2021-12-17 | 120,000 | — | $0 | 120,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy | 2021-06-15 | 2021-06-17 | 11,764 | $8.50 | $100.0K | 11,764 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-03 | 2021-06-04 | 9,492 | $21.96 | $208.4K | 122,196 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 2,517 | $22.32 | $56.2K | 146,807 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 12,483 | $21.50 | $268.4K | 149,324 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 12,732 | $21.51 | $273.9K | 134,075 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 2,387 | $22.31 | $53.3K | 131,688 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 33,189 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 5,254 | $23.57 | $123.8K | 161,807 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 33,189 | — | $0 | 176,807 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 9,746 | $22.72 | $221.4K | 167,061 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-05-07 | 2021-05-07 | 5,416 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-07 | 2021-05-07 | 3,316 | $23.23 | $77.0K | 145,718 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-05-07 | 2021-05-07 | 5,416 | $10.66 | $57.7K | 149,034 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-07 | 2021-05-07 | 2,100 | $23.99 | $50.4K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-05-06 | 2021-05-07 | 15,000 | — | $0 | 5,416 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-06 | 2021-05-07 | 3,102 | $23.86 | $74.0K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-06 | 2021-05-07 | 11,898 | $23.32 | $277.5K | 146,720 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-05-06 | 2021-05-07 | 15,000 | $10.66 | $159.9K | 158,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-05-05 | 2021-05-05 | 15,000 | — | $0 | 20,416 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-05 | 498 | $24.36 | $12.1K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-05 | 14,502 | $23.97 | $347.6K | 144,116 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-05-05 | 2021-05-05 | 15,000 | $10.66 | $159.9K | 158,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-05-04 | 2021-05-05 | 15,000 | — | $0 | 35,416 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-05-04 | 2021-05-05 | 15,000 | $10.66 | $159.9K | 158,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-05 | 1,279 | $24.47 | $31.3K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-05 | 13,721 | $23.61 | $324.0K | 144,897 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-05-03 | 2021-05-05 | 15,000 | — | $0 | 50,416 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-05 | 4,339 | $24.91 | $108.1K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-05-03 | 2021-05-05 | 15,000 | $10.66 | $159.9K | 158,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-05 | 10,661 | $24.46 | $260.8K | 147,957 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | G Gift | 2021-03-11 | 2021-11-22 | 7,500 | — | $0 | 114,696 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-02 | 2021-03-03 | 6,637 | — | $0 | 19,914 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-02 | 2021-03-03 | 6,637 | — | $0 | 145,524 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-02 | 2021-03-03 | 1,906 | $23.25 | $44.3K | 143,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 99,500 | — | $0 | 99,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 17,175 | — | $0 | 34,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 17,175 | — | $0 | 143,821 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-01 | 2021-03-03 | 4,934 | $24.06 | $118.7K | 138,887 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,875 | — | $0 | 3,875 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-02-01 | 2021-02-03 | 1,318 | $21.35 | $28.1K | 126,646 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 3,875 | — | $0 | 127,964 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-12-15 | 2020-12-17 | 1,734 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-12-15 | 2020-12-17 | 1,734 | — | $0 | 124,587 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-12-15 | 2020-12-17 | 498 | $4.59 | $2.3K | 124,089 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2020-06-23 | 2020-06-25 | 3,033 | — | $0 | 3,033 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-01 | 2020-06-03 | 33,188 | — | $0 | 33,189 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-01 | 2020-06-03 | 33,188 | — | $0 | 132,387 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-06-01 | 2020-06-03 | 9,534 | $1.32 | $12.6K | 122,853 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 17,175 | — | $0 | 51,525 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 66,377 | — | $0 | 66,377 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 92,928 | — | $0 | 92,928 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 26,551 | — | $0 | 26,551 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 4,779 | $1.26 | $6.0K | 99,199 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 17,175 | — | $0 | 103,978 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2020-02-21 | 2020-02-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-02-03 | 2020-02-04 | 3,875 | — | $0 | 7,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-02-03 | 2020-02-04 | 1,318 | $1.28 | $1.7K | 86,803 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-02-03 | 2020-02-04 | 3,875 | — | $0 | 88,121 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-18 | 2019-12-20 | 1,075 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-18 | 2019-12-20 | 277 | $1.81 | $501 | 84,246 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-18 | 2019-12-20 | 1,075 | — | $0 | 84,523 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 1,733 | — | $0 | 1,734 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-16 | 2019-12-18 | 497 | $1.80 | $895 | 83,448 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 1,733 | — | $0 | 83,945 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 68,700 | — | $0 | 68,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 11,625 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 1,308 | $6.96 | $9.1K | 82,212 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 83,520 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-18 | 2018-12-20 | 1,075 | — | $0 | 1,075 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-18 | 2018-12-20 | 306 | $6.30 | $1.9K | 79,645 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-18 | 2018-12-20 | 1,075 | — | $0 | 79,951 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-15 | 2018-12-18 | 1,733 | — | $0 | 3,467 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-15 | 2018-12-18 | 493 | $7.31 | $3.6K | 78,876 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-15 | 2018-12-18 | 1,733 | — | $0 | 79,369 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2018-06-12 | 2018-06-12 | 4,900 | $20.00 | $98.0K | 77,636 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2018-06-11 | 2018-06-12 | 100 | $20.00 | $2.0K | 82,536 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2018-05-18 | 2018-05-21 | 10,000 | $20.00 | $200.0K | 82,636 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-05-07 | 2018-05-09 | 6,933 | — | $0 | 5,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-05-07 | 2018-05-09 | 6,933 | — | $0 | 94,610 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-05-07 | 2018-05-09 | 1,974 | $18.10 | $35.7K | 92,636 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2018-03-16 | 2018-03-20 | 9,018 | — | $0 | 87,677 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 15,500 | — | $0 | 15,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 54,000 | — | $0 | 54,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-21 | 1,075 | — | $0 | 2,150 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-18 | 2017-12-21 | 1,075 | — | $0 | 78,986 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-18 | 2017-12-21 | 327 | $24.12 | $7.9K | 78,659 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-21 | 1,733 | — | $0 | 12,133 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-15 | 2017-12-21 | 527 | $24.23 | $12.8K | 77,911 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-21 | 1,733 | — | $0 | 78,438 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-12-18 | 2016-12-20 | 1,075 | — | $0 | 3,225 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2016-12-18 | 2016-12-20 | 327 | $31.25 | $10.2K | 76,705 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-12-18 | 2016-12-20 | 1,075 | — | $0 | 77,032 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 83,200 | — | $0 | 83,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 13,866 | — | $0 | 13,866 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-10-26 | 2016-10-28 | 3,912 | — | $0 | 6,522 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-10-26 | 2016-10-28 | 3,912 | $21.83 | $85.4K | 75,957 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-10-26 | 2016-10-28 | 3,912 | $1.52 | $5.9K | 79,869 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-09-28 | 2016-09-28 | 1,841 | $0.72 | $1.3K | 77,798 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-09-28 | 2016-09-28 | 1,841 | $24.66 | $45.4K | 75,957 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-09-26 | 2016-09-28 | 1,841 | — | $0 | 2,176 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2016-09-15 | 2016-09-19 | 50,878 | — | $0 | 71,167 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2016-09-15 | 2016-09-19 | 4,790 | — | $0 | 75,957 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-08-26 | 2016-08-29 | 3,738 | $20.35 | $76.1K | 20,289 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 45,939 | — | $0 | 45,939 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 4,300 | — | $0 | 4,300 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 10,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,901 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 3,738 | — | $0 | 24,027 | SEC↗ |